$STZ

Constellation Brands Reaffirms Fiscal 2027 Adjusted EPS Guidance

Constellation Brands (STZ.B) reaffirmed its fiscal 2027 adjusted EPS guidance of $11.20 to $11.90 during its earnings call. The company is a leading US producer of alcoholic beverages, with a market value of $47.02 billion and trailing 12-month revenue of $9.82 billion. Its stock trades at $310.00, 10.5% below its GF Value of $346.51.

Original reporting
Published Oct 8, 2026, 10:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 10:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Neutral
high confidence
Mentioned
$STZ
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$STZNeutralMed
01

Why it matters

The reaffirmed FY2027 EPS range provides clarity for analysts and may limit speculative upside.

02

Market read

Guidance reaffirmation offers a modest trading signal for STZ with limited broader market effect.

03

What to watch

Potential cost‑inflation pressures in raw materials could affect future margins despite stable guidance.

Relevance 7/10Novelty 7/10Timing: after earnings call today

Background

Constellation Brands is a leading US alcoholic beverage producer with a market cap of ~$47 B.

Company-level read

Ticker impact

$STZNeutralHigh confidence
Context

Constellation Brands reaffirmed its FY2027 adjusted EPS guidance of $11.20‑$11.90 on its earnings call.

Expected impact

likely modest pressure as investors price in unchanged outlook

Evidence & confidence

No change to guidance limits upside; any prior anticipation of a raise could trigger sell pressure.

Market effects

Stable guidance may keep consumer staples sector unchanged in the short term.

Limited to US and North American beverage markets.

Minimal global impact beyond the alcoholic beverage segment.

Counterpoint

Investors could view the reaffirmation as a sign of confidence and hold the stock despite no upgrade.

Key entities

  • Constellation Brands

    US alcoholic beverage producer.

Related articles

$STZMed

STZ Maintained by Morgan Stanley -- Price Target Lowered to $145

Morgan Stanley maintained Constellation Brands (STZ) at Equal-Weight but lowered its price target to $145 from $158, citing a cautious outlook in the competitive beverage market. GuruFocus values STZ at $172.88, suggesting a 31.5% undervaluation at its current price of $118.39, with a P/E (TTM) of 10.62x. The company's GF Score is 59/100, indicating moderate overall performance.

$STZMed

Why is Constellation Brands stock sliding today?

Constellation Brands (STZ) fell 1.1% in pre-market trading after HSBC downgraded it to Hold and cut its price target to $135. The company's Q2 2027 earnings showed mixed results, with adjusted EPS of $3.74 and net sales of $2.63B beating estimates, but beer depletions fell 0.6%. Analysts had mixed reactions, with some cutting price targets but maintaining bullish ratings, while others kept Buy ratings. The broader market downturn also contributed to the slide.